Should Invivo Therapeutics Holdings Corp (NVIV) Stock be in Your Portfolio?

Invivo Therapeutics Holdings Corp (NVIV) stock has fallen -79.31% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NVIV stock a score of 5 out of a possible 100.

That rank is influenced by a fundamental score of 0. . NVIV's rank also includes a short-term technical score of 4. The long-term technical score for NVIV is 12.

NVIV has an Overall Score of 5. Find out what this means to you and get the rest of the rankings on NVIV!

See Full NVIV Report

What's Happening with NVIV Stock Today

Invivo Therapeutics Holdings Corp (NVIV) stock has gained 9.05% while the S&P 500 is higher by 0.16% as of 9:45 AM on Wednesday, Feb 3. NVIV is higher by $0.11 from the previous closing price of $1.16 on volume of 995,910 shares. Over the past year the S&P 500 has risen 16.22% while NVIV has fallen -79.31%. NVIV lost -$11.65 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Invivo Therapeutics Holdings Corp (NVIV) Stock.